$115.9M
11-50
Axial Therapeutics is a biopharmaceutical company using the gut-brain axis to create innovative treatments for the Central Nervous System. Their focus is on developing new therapies that target this connection to improve brain health.
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
City Rank
Share
4th
In Woburn
out of 27 startups
National Rank
Share
1,224th
In United States
out of 8869 startups
Regional Rank
Share
1,275th
In North America
out of 9671 startups
City Rank
Share
1st
In Woburn
out of 17 startups
National Rank
Share
443rd
In United States
out of 3470 startups
Regional Rank
Share
456th
In North America
out of 3721 startups
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...